SSA
ALXO icon

Schonfeld Strategic Advisors’s ALX Oncology ALXO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-104,600
Closed -$1.56M – 2039
2023
Q4 		$1.56M Buy
+104,600
New +$992K 0.01% 887
2022
Q4 		– Sell
-17,400
Closed -$166K – 2560
2022
Q3 		$166K Sell
17,400
-39,400
-69% -$459K ﹤0.01% 2407
2022
Q2 		$459K Buy
56,800
+23,900
+73% +$260K ﹤0.01% 1411
2022
Q1 		$556K Buy
+32,900
New +$562K 0.01% 1299

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Schonfeld Strategic Advisors's ALXO Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of ALX Oncology (ALXO) in Q1 2024, closing a stake of 104,600 shares — an estimated $1.56M sold.

Schonfeld Strategic Advisors first reported a position in ALXO in Q1 2022 and held it in 4 quarters. The position peaked at $1.56M in Q4 2023. 106 funds tracked by Wall St. Rank hold ALXO as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining ALX Oncology position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 104,600 ALX Oncology shares in Q1 2024, an estimated $1.56M.
  • Schonfeld Strategic Advisors first reported a position in ALX Oncology in Q1 2022 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's ALX Oncology position peaked at $1.56M in Q4 2023.
  • 106 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.